Antidepressants in bipolar disorder: Beware of risks!;Les antidépresseurs dans la dépression bipolaire: Attention aux risques

Revue Medicale de Liege

Volumn 63, Issue 5-6, 2008, Pages 391-395

  Pitchot, W ^a   Scantamburlo, G ^a   Ansseau, M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Antidepressants; Atypical antipsychotics; Bipolar depression; Lamotrigine

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LAMBIPOL; LAMOTRIGINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; OLANZAPINE; PAROXETINE; PLACEBO; QUETIAPINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE;

BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL PRACTICE; CONSTIPATION; CYCLOTHYMIA; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HOSPITALIZATION; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MONOTHERAPY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRESCRIPTION; REMISSION; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; TREATMENT FAILURE; TREATMENT OUTCOME; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; HUMANS; RISK FACTORS;

EID: 47249157779     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Souery D, Staner L, Zdanowicz N, et al. - la dépression bipolaire : la face cachée de l'iceberg. Acta Psychiatrica Belgica, 2005, 105, 131-139.
2. Hirschfeld RM, Lewis L, Vornik LA. - Perceptions and impact of bipolar disorder : how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry, 2003, 64, 161-174.
3. Truman CJ, Goldberg JF, Ghaemi SN, et al. - Self-reported history of manic/hypomanic switch associated with antidepressant use : data from the Systematic treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry, 2007, 68, 1472-1479.
4. Gijsman HJ, Geddes JR, Rendell JM, et al. - Antidepressants fro bipolar depression : a systematic review of randomized, controlled trials. Am J Psychiatry, 2004, 161, 1537-1547.
5. Goldberg JF, Truman CJ. - Antidepressant-induced mania : an overview of current controversies. Bipolar Disord, 2003, 5, 407-420.
6. Ghaemi SN, Rosenquist KJ, Ko JY, et al. - Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry, 2004, 161, 163-165.
7. Leverich GS, Altshuler LL, Frye MA, et al. - Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry, 2006, 163, 232-239.
8. Sachs GS, Nierenberg AA, Calabrese JR, et al. - Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med, 2007, 356, 1711-1722.
9. Altshuler L, Suppes T, Black D, et al. - Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry, 2003, 160, 1252-1262.
10. Calabrese JR, Bowden CL, Sachs GS, et al. - A double-blind placebo- controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamicta 602 study Group. J Clin Psychiatry, 1999, 60, 79-88.
11. Calabrese JR, Bowden CL, Sachs GS, et al. - A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry, 2003, 64, 1013-1024.
12. Bowden CL, Calabrese JR, Sachs GS, et al. - A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry, 2003, 60, 392-400.
13. Derry S, Moore RA. - Atypical antipsychotics in bipolar disorder : systematic review of randomised trials. BMC Psychiatry, 2007, 16, 7-40.
14. Tohen M, Vieta E, Calabrese J, et al. - Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry, 2003, 60, 1079-1088.
15. Calabrese JR, Keck Jr PE, Macfadden W, et al. - A randomised double-blind placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry, 2005, 162, 1351-1360.
16. Thase ME, Macfadden W, Weisler RH, et al. - Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol, 2006, 26, 600-609.